Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Income from Continuing Operations (2016 - 2025)

iBio (IBIO) has disclosed Income from Continuing Operations for 16 consecutive years, with 8993000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 106.07% to 8993000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 24737000.0, a 62.38% decrease, with the full-year FY2025 number at 18377000.0, down 11.76% from a year prior.
  • Income from Continuing Operations was 8993000.0 for Q4 2025 at iBio, down from 5720000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3246000.0 in Q2 2024 to a low of 10563000.0 in Q4 2022.
  • A 5-year average of 6292700.0 and a median of 5758500.0 in 2021 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: plummeted 167.78% in 2021, then skyrocketed 57.51% in 2023.
  • iBio's Income from Continuing Operations stood at 7196000.0 in 2021, then crashed by 46.79% to 10563000.0 in 2022, then surged by 57.51% to 4488000.0 in 2023, then grew by 2.76% to 4364000.0 in 2024, then tumbled by 106.07% to 8993000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Income from Continuing Operations are 8993000.0 (Q4 2025), 5720000.0 (Q3 2025), and 5163000.0 (Q2 2025).